Actionable news
0
All posts from Actionable news
Actionable news in REGN: Regeneron Pharmaceuticals, Inc.,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

SEC Form 4

FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
YANCOPOULOS GEORGE
(Last) (First) (Middle)
777 OLD SAW MILL RIVER ROAD
(Street)
TARRYTOWN NY 10591
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REGENERON PHARMACEUTICALS INC [ REGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President Regeneron Laboratori
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/30/2015 M (1) 182,818 A $11.64 682,818 D
Common Stock 10/30/2015 F (1) 3,806 D $559.08 679,012 D
Common Stock 10/30/2015 F (1) 92,316 D $559.08 586,696 D
Common Stock 11/02/2015 S (1) 1,200 D $561.75 (2) 585,496 D
Common Stock 11/02/2015 S (1) 100 D $562.36 585,396 D
Common Stock 11/02/2015 S (1) 530 D $563.76 (3) 584,866 D
Common Stock 11/02/2015 S (1) 1,000 D $564.57 (4) 583,866 D
Common Stock 11/02/2015 S (1) 1,000 D $565.89 (5) 582,866 D
Common Stock 11/02/2015 S (1) 1,700 D $566.66 (6) 581,166 D
Common Stock 11/02/2015 S (1) 1,350 D $567.61 (7) 579,816 D
Common Stock 11/02/2015 S (1) 1,600 D $568.49 (8) 578,216 D
Common Stock 11/02/2015 S (1) 2,223 D $569.47 (9) 575,993 D
Common Stock 11/02/2015 S (1) 6,330 D $570.67 (10) 569,663 D
Common Stock 11/02/2015 S (1) 7,800 D $571.41 (11) 561,863 D
Common Stock 11/02/2015 S (1) 5,723 D $572.43 (12) 556,140 D
Common Stock 11/02/2015 S (1) 2,629 D $573.47 (13) 553,511 D
Common Stock 11/02/2015 S (1) 2,693 D $574.55 (14) 550,818 D
Common Stock 11/02/2015 S (1) 2,441 D $575.64 (15) 548,377 D
Common Stock 11/02/2015 S (1) 865 D $576.48 (16) 547,512 D
Common Stock 11/02/2015 S (1) 1,996 D $577.58 (17) 545,516 D
Common Stock 11/02/2015 S (1) 268 D $578.73 (18) 545,248 D
Common Stock 11/02/2015 S (1) 1,500 D $579.53 (19) 543,748 D
Common Stock 11/02/2015 S (1) 400 D $580.29 (20) 543,348 D
Common Stock 5,654 I By 401(k) Plan
Common Stock 569,588 I by Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable...

More